In the case of anti-CD19 CAR T cells, human CD8α hinge and transmembrane molecules did not promote efficacies differently against tumor xenografts but induced lower cytokine levels compared with CD28 hinge and transmembranes [138,139]. The gene discussed is CD8A; the disease is neoplasm.